Ventana launches modular staining system:
This article was originally published in Clinica
Ventana Medical Systems has launched NexES, a new automated immunohistochemistry (IHC) staining system designed for small hospitals in the US. Ventana's fully-automated ES II and Gen II cancer diagnostic systems are aimed primarily at bigger hospitals. The NexES system has been designed on a modular basis that enables customers to tailor its use to their individual workloads. This, says Ventana, will enable it to penetrate the 3,900 US hospitals that have less than 200 beds.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.